Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3512-3517

  Zhang, Zhong Ting ^a   Pak, Joanne ^b   Shapiro, Ellen ^a   Sun, Tung Tien ^a   Wu, Xue Ru ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GENE PRODUCT; PROTEIN P53; VIRUS LARGE T ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CARCINOGENESIS; CARCINOMA IN SITU; DNA SEQUENCE; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TRANSGENE; TRANSGENIC MOUSE; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CARCINOMA IN SITU; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; ONCOGENES; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SIMIAN VIRUS 40; TRANSGENES; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0033565558     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 1998.
2. Koss, L. G. Bladder cancer from a perspective of 40 years. J. Cell. Biochem. Suppl., 161: 23-29, 1992.
3. Grossman, H. B. Superficial bladder cancer: decreasing the risk of recurrence. Oncology, 10: 1617-1624, 1996.
4. Steinberg, G. D., Trump, D. L., and Cummings K. D. Metastatic bladder cancer. Urol. Clin. North Am., 19: 735-746, 1992.
5. Heney, N. M. Natural history of superficial bladder cancer. Urol. Clin. North Am., 19: 429-433, 1992.
6. Lamm, D. L. Carcinoma in situ. Urol. Clin. North Am., 19: 499-508, 1992.
7. Schalken, J. A., van Moorselaar, R. J., Bringuier, P. P., and Debruyne, F. M. Critical review of the models to study the biologic progression of bladder cancer. Semin. Surg. Oncol., 8: 274-278, 1992.
8. Farrow, G. M. Pathology of carcinoma in situ of the urinary bladder and related lesions. J. Cell Biochem. Suppl., 161: 39-43, 1992.
9. Hudson, M. A., and Herr, H. W. Carcinoma in situ of the bladder. J. Urol., 153: 564-572, 1995.
10. Reznikoff, C. A., Belair, C. D., Yeager, T. R., Savelieva, E., Blelloch, R. H., Puthenveettil, J. A., and Cuthill, S. A molecular genetic model of human bladder cancer. Semin. Oncol., 23: 571-584, 1996.
11. Spruck, C. H., III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G., and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788, 1994.
12. Rosin, M. P., Cairns, P., Epstein, J. I., Schoenberg, M. P., and Sidransky, D. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res., 55: 5213-5216, 1995.
13. Wagner, U. R. S., Sauter, G., Moch, H., Novotna, H., Epper, R., Mihatsch, M. J., and Waldman, F. M. Patterns of p53, erbB-2 and EGF-r expression in premalignant lesions of the urinary bladder. Hum. Palhol., 26: 970-978, 1995.
14. Borland, R. N., Brendler, C. B., and Issacs, W. B. Molecular biology of bladder cancer. Hematol. Oncol. Clin. North Am., 6: 31-39, 1992.
15. Cairns, P., Proctor, A. J., and Knowles, M. A. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene, 6: 2305-2309, 1991.
16. Coombs, L. M., Pigott, D. A., and Sweeney, E. Amplification and overexpression of c-erb-B2 in transitional cell carcinoma of the urinary bladder. Br. J. Cancer, 63: 601-608, 1991.
17. Czerniak, B., Cohen, G. L., Etkind, P., Deitch, D., Simmons, H., Herz, F., and Koss, L. G. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum. Pathol., 23: 1199-1204, 1992.
18. Messing, E. M. Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors. Semin. Surg. Oncol., 8: 285-292, 1992.
19. Cordon-Cardo, C., Dalbagni, C. G., Sarkis, A. S., and Reuter, V. E. Genetic alterations associated with bladder cancer. In: V. T. DeVita, S. Hellman and S. A. Rosenberg (eds.). Important Advances in Oncology, 71-83. Philadelphia: J. B. Lippincott Company, 1994.
20. Schmitz-Drager, B. J., Schulz, W. A., Jurgens, B., Gerharz, C. D., van Roeyen, C. R., Bultel, H., Ebert, T., and Ackermann, R. c-myc in bladder cancer. Clinical findings and analysis of mechanism. Urol. Res., 25 (Suppl. 1): S45-S49, 1997.
21. Lin, J-H., Zhao, H., and Sun, T-T. A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc. Natl. Acad. Sci. USA, 92: 679-683, 1995.
22. Kerr, D. E., Liang, F., Bondioli, K. R., Zhao, H., Kreibich, G., Wall, R. J., and Sun, T-T. The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nat. Biotechnol., 16: 75-79, 1998.
23. Bryan, T. M., and Reddel, R. R. SV40-induced immortalization of human cells. Crit. Rev. Oncog., 5: 331-357, 1994.
24. Cordon-Cardo, C., Sheinfeld, J., and Dalbagni, G. Genetic studies and molecular markers of bladder cancer. Semin. Surg. Oncol., 13: 319-327, 1997.
25. Li, Q., Karam, S. M., and Gordon, J. I. Simian virus 40 T antigen-induced amplification of pre-parietal cells in transgenic mice. J. Biol. Chem., 270: 15777-15788, 1995.
26. Brinster, R. L., Chen, H. Y., Trumbauer, M., Senear, A. W., Warren, R., and Palmiter, R. D. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell, 27: 223-231, 1981.
27. Hanahan, D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature (Lond.), 315: 115-122, 1985.
28. Wu, X-R., and Sun, T-T. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J. Cell Sci., 106: 31-43, 1993.
29. Wu, X-R., Manabe, M., Yu, J., and Sun, T-T. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J. Biol. Chem., 265: 19170-19179, 1990.
30. Moll, R., Wu, X-R., Lin, J. H., and Sun, T-T. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am. J. Pathol., 147: 1383-1397, 1995.
31. Wu, R-L., Osman, I., Wu, X-R., Lu, M. L., Zhang, Z. F., Liang, F. X., Hamza, R., Scher, H., Cordon-Cardo, C., and Sun, T-T. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res., 58: 1291-1297, 1998.
32. Meyer-Puttlitz, B., Lin, J. H., Sun, T-T., and Margolis, R. K. Ectopic expression of a bacterial lacZ gene in the limbic system of transgenic mice. Neuroreport, 6: 1674-1678, 1995.
33. Miller, S. J., Lavker, R. M., and Sun, T-T. Keratinocyte stem cells of cornea, skin and hair follicle: common and distinguishing features. Semin. Dev. Biol., 4: 217-240, 1993.
34. Kuhn, R., and Schwenk, F. Advances in gene targeting methods. Curr. Opin. Immunol., 9: 183-188, 1997.
35. Melicow, M. W., and Hollowell, J. W. Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases. J. Urol., 68: 763-772, 1952.
36. Koss, L. G. Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum. Pathol., 10: 533-548, 1979.
37. Cote, R. J., Dunn, M. D., Chatterjee, S. J., Stein, J. P., Shi, S. R., Tran, Q. C., Hu, S. X., Xu, H. J., Groshen, S., Taylor, C. R., Skinner, D. G., and Benedict, W. F. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res., 58: 1090-1094, 1998.
38. Cordon-Cardo, C., Zhang, Z. F., Dalbagni, G., Drobnjak, M., Charytonowicz, E., Hu, S. X., Xu, H. J., Reuter, V. E., and Benedict, W. F. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res., 57: 1217-1221, 1997.
39. Grossman, H. B., Liebert, M., Antelo, M., Dinney, C. P., Hu, S. X., Palmer, J. L., and Benedict, W. F. p53 and RB expression predict progression in T1 bladder cancer. Clin. Cancer Res., 4: 829-834, 1998.
40. Simoneau A. R., and Jones, P. A. Bladder cancer: the molecular progression to invasive disease. World J. Urol., 12: 89-95, 1994.
41. Cordon-Cardo, C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol., 147: 545-560, 1995.
42. Knowles, M. A. Molecular genetics of bladder cancer. Brit. J. Urol., 75 (Suppl.): 57-66, 1995.
43. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
44. Campbell, S. C., Volpert, O. V., Ivanovich, M., and Bouck, N. P. Molecular mediators of angiogenesis in bladder cancer. Cancer Res., 58: 1298-1304, 1998.
45. Cohen, S. M., and Ellwein, L. B. Cell proliferation in carcinogenesis. Science (Washington DC), 249: 1007-1011, 1990.
46. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
47. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
48. Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Frye, C., Eeles, R., Orlow, I., Lacombe, L., Ponce-Castaneda, V., Lianes, P., Latres, E., Skolnick, M., Cordon-Cardon, C., and Kamb, A. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am. J. Pathol., 146: 1199-1206, 1995.
49. Orlow, I., Lacombe, L., Hannon, G. J., Serrano, M., Pellicer, I., Dalbagni, G., Reuter, V. E., Zhang, Z. F., Beach, D., and Cordon-Cardo, C. Deletion of the p16 and p15 genes in human bladder tumors. J. Natl. Cancer Inst., 87: 1524-1529, 1995.
50. Benedict, W. F., Lerner, S. P., Zhou, J. Shen, X., Tokunaga, H., and Czerniak, B. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/ CDKN2) status in bladder cancer. Oncogene, 18: 1197-1203, 1999.
51. Li, S., Zhang, Z-T., Chan, S., McClenan, O., Lepor, H., Dixon, C., Sun, T-T., and Wu, X-R. Detection of circulating uroplakin-positive cells in patients with metastatic bladder cancer. J. Urol., in press, 1999.